2016
DOI: 10.3389/fbioe.2016.00047
|View full text |Cite
|
Sign up to set email alerts
|

Upconversion Nanoparticles for Bioimaging and Regenerative Medicine

Abstract: Nanomaterials are proving useful for regenerative medicine in combination with stem cell therapy. Nanoparticles (NPs) can be administrated and targeted to desired tissues or organs and subsequently be used in non-invasive real-time visualization and tracking of cells by means of different imaging techniques, can act as therapeutic agent nanocarriers, and can also serve as scaffolds to guide the growth of new tissue. NPs can be of different chemical nature, such as gold, iron oxide, cadmium selenide, and carbon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
48
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 77 publications
(48 citation statements)
references
References 119 publications
(172 reference statements)
0
48
0
Order By: Relevance
“…The tumor-bearing mice were first injected with N 3 -DSPE-PEG-CCm 231 -UCNPs, N 3 -DSPE-PEG-RBCm-UCNPs, or N 3 -DSPE-PEG, and then 24 h after the injection, Al[ 18 F]F-L-NETA-DBCO was subsequently injected into the tumor-bearing mice via tail vein. First, L-NETA-DBCO was successfully radiolabeled with 18 F via Al-18 F chelation [33], and then, 18 F-labeled aza-dibenzocyclooctyne (DBCO) radioligands (Al[ 18 F] F-L-NETA-DBCO) were conjugated with azide-modified UCNPs by in vivo strain-promoted alkyne azide cycloaddition (SPAAC), which enables PET imaging [34]. PET static imaging was performed at 0.5, 1, 2, and 4 h after the injection of Al [ 18…”
Section: In Vivo Imagingmentioning
confidence: 99%
“…The tumor-bearing mice were first injected with N 3 -DSPE-PEG-CCm 231 -UCNPs, N 3 -DSPE-PEG-RBCm-UCNPs, or N 3 -DSPE-PEG, and then 24 h after the injection, Al[ 18 F]F-L-NETA-DBCO was subsequently injected into the tumor-bearing mice via tail vein. First, L-NETA-DBCO was successfully radiolabeled with 18 F via Al-18 F chelation [33], and then, 18 F-labeled aza-dibenzocyclooctyne (DBCO) radioligands (Al[ 18 F] F-L-NETA-DBCO) were conjugated with azide-modified UCNPs by in vivo strain-promoted alkyne azide cycloaddition (SPAAC), which enables PET imaging [34]. PET static imaging was performed at 0.5, 1, 2, and 4 h after the injection of Al [ 18…”
Section: In Vivo Imagingmentioning
confidence: 99%
“…10 Other advantages of the particles include minimum autofluorescence, a large anti-Stokes shift, narrow emission bandwidths and low scattering, which strongly decreases with increasing wavelength (∼1/λ 4 ). 11 The upconversion nanoparticles composed of a NaYF 4 crystal host lattice and doped by an optically active Yb 3+ /Er 3+ ion pair are able after the sequential absorption of two or more low-energy NIR photons to convert them into high-energy visible emission, which may subsequently serve for efficient photodynamic or photothermal therapy in situ. 12,13 Upconversion nanoparticles are thus highly promising for various applications in biological fields, such as in vitro cell labelling, 14 in vivo multimodal imaging and cell tracking, 15 controlled drug delivery, 16 photodynamic therapy, photoacoustic therapy, 17 and photothermal therapy.…”
Section: Introductionmentioning
confidence: 99%
“…Recently,u pconversion nanomaterials have shown great promise for av ariety of applications ranging from solar energy conversion [1,2] and security areas [3] and even to biomedicine [4] for nanothermometry, [5] drug delivery, [6] early-stage in vivo bioimaging, [7,8] andt reatment of canceru sing photothermal [9] and photodynamic therapy (PDT). [10,11] PDT is an alternative to conventional treatments,s uch as surgery,c hemotherapy,a nd radiotherapy,d ue to its low toxicity andm inimal side effects on normalcells.…”
Section: Introductionmentioning
confidence: 99%